Convatec Group (CTEC)

Sector:

Health Care

Index:

FTSE 250

202.80p
   
  • Change Today:
      0.90p
  • 52 Week High: 217.30
  • 52 Week Low: 118.55
  • Currency: UK Pounds
  • Shares Issued: 1,983.51m
  • Volume: 29,404
  • Market Cap: £4,022.57m
  • RiskGrade: 139

CTEC Overview

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Its products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Based in Reading, it employs over 9,000 people in more than 100 countries.
Competitors: Akers Biosciences, Inc., Consort Medical, Advanced Medical Solutions

Key Personnel

Chairman: John McAdam
CEO: Karim Bitar
CFO: Frank Schulkes
Senior Independent Director: Margaret Ewing
Non-Executive Dir: Sten Scheibye, Regina Benjamin, Rick Anderson, Ros Rivaz

Contact Details

Address: 3, Forbury Place, 23 Forbury Road, Reading, United Kingdom, RG1 3JH
Website: http://www.convatecgroup.com

Listings

Sector: Health Care(LSE)
Index: FTSE 250FTSE 350FTSE All-Share
ISIN: GB00BD3VFW73

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CTEC Market Data

Currency UK Pounds
Share Price 202.80p
Change Today 0.90p
% Change 0.45 %
52 Week High 217.30
52 Week Low 118.55
Volume 29,404
Shares Issued 1,983.51m
Market Cap £4,022.57m
RiskGrade 139

CTEC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.8% below the market average66.8% below the market average66.8% below the market average66.8% below the market average66.8% below the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average
Price Trend
65.05% above the market average65.05% above the market average65.05% above the market average65.05% above the market average65.05% above the market average
65.00% above the sector average65.00% above the sector average65.00% above the sector average65.00% above the sector average65.00% above the sector average
Income
38.93% below the market average38.93% below the market average38.93% below the market average38.93% below the market average38.93% below the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average
Growth
10.94% below the market average10.94% below the market average10.94% below the market average10.94% below the market average10.94% below the market average
23.53% below the sector average23.53% below the sector average23.53% below the sector average23.53% below the sector average23.53% below the sector average

What The Brokers Say

Strong Buy 5
Buy 1
Neutral 7
Sell 1
Strong Sell 2
Total 16
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CTEC Dividends

  Latest Previous
  Interim Final
Ex-Div 05-Sep-19 04-Apr-19
Paid 17-Oct-19 16-May-19
Amount 1.72¢ 3.98¢

Trades for 28-Jan-2020

Time Volume / Share Price
08:16 392 @ 202.80p
08:16 1,043 @ 202.60p
08:16 2,326 @ 202.60p
08:16 804 @ 202.70p
08:16 775 @ 202.70p

CTEC Key Personnel

CFO Frank Schulkes
CEO Karim Bitar
Chair John McAdam

Top of Page